Importantly, we show that the degranulation and cytotoxicity of NK cells from patients with CHS could be restored by modulating the cortical actin meshwork density at the immunologic synapse or by decreasing the size of enlarged granules in LYST-deficient NK cells, suggesting new possibilities for CHS therapy. The gene discussed is LYST; the disease is Chédiak-Higashi syndrome.